ArticlePeerJ2024

Neoadjuvant chemotherapy efficacy and prognosis in HER2-low and HER2-zero breast cancer patients by HR status: a retrospective study in China.

Shaorong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.